Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocryst Pharmaceuticals buy Evercore Inc.

Biocryst Pharmaceuticals
Start price
€6.00
18.02.26 / 50%
Target price
€14.35
18.02.27
Performance (%)
49.37%
Price
€8.96
11.08.26
Summary
This prediction is currently active. With a performance of 49.37% the BUY prediction by Evercore_Inc_ is a big success. This prediction currently runs until 18.02.27. The prediction end date can be changed by Evercore_Inc_ at any time. Evercore_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Biocryst Pharmaceuticals 14.370% 14.370%
iShares Core DAX® 1,00 % 4,83 %
iShares Nasdaq 100 2,70 % -1,72 %
iShares Nikkei 225® 3,52 % -3,51 %
iShares S&P 500 1,77 % 1,27 %

Comments by Evercore_Inc_ for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 49.37%
Target price 14.351
Change
Ends at 18.02.27

BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat

Evercore Inc. 
0
Report Share
18.02.26